Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 5.914E-12 | 1.288E-08 | CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR2, PTPN1 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 1.377E-31 | 2.999E-27 | CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 7.633E-25 | 8.310E-21 | CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 3.375E-06 | 5.249E-03 | CA2, CA7 |
BP | GO:0009987; cellular process | GO:1902202; regulation of hepatocyte growth factor receptor signaling pathway | 6.746E-06 | 9.180E-03 | PTPN1, PTPN2 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 4.450E-23 | 2.422E-19 | CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00910 | Nitrogen metabolism_Homo sapiens_hsa00910 | 8.508E-31 | 2.467E-29 | CA12; CA1; CA3; CA5B; CA2; CA5A; CA4; CA7; CA6; CA9; CA14 |
hsa04964 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.622E-04 | 3.801E-03 | CA2; CA4 |
hsa00830 | Retinol metabolism_Homo sapiens_hsa00830 | 2.099E-03 | 2.029E-02 | CYP2A6; ALDH1A1 |
hsa00232 | Caffeine metabolism_Homo sapiens_hsa00232 | 5.240E-03 | 3.799E-02 | CYP2A6 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Infections | A00-B99 | PTPN1 |
H00-H59: Diseases of the eye and adnexa | Chronic glaucoma | H40-H42 | CA1 |
NA: NA | Edema | NA | CA2 |
C00-D49: Neoplasms | Cancer | C00-C96 | CA1; CA9 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Major depressive disorder | F32, F33, M32 | HCAR2 |
I00-I99: Diseases of the circulatory system | Acute ischemic stroke | I61-I63 | HCAR2 |
C00-D49: Neoplasms | Renal cancer | C64 | CA9 |
I00-I99: Diseases of the circulatory system | Cardiovascular disorder | I00-I99 | HCAR2 |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetes | E23.2, N25.1 | PTPN1 |
C00-D49: Neoplasms | Breast cancer | C50 | CA9 |
C00-D49: Neoplasms | Thyroid cancer diagnosis | C73 | TSHR |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | PTPN1; PTPN1; HCAR2 |
C00-D49: Neoplasms | Solid tumours | C00-D48 | CA9 |
E00-E89: Endocrine, nutritional and metabolic diseases | Obesity | E66 | PTPN1 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CA2 |
C00-D49: Neoplasms | Lymphoma | C81-C86 | CA9 |
I00-I99: Diseases of the circulatory system | Edema associated with congestive heart failure | I50, R60.9 | CA2 |
K00-K95: Diseases of the digestive system | Duodenal ulcers | K25-K27 | CA1; CA2 |
E00-E89: Endocrine, nutritional and metabolic diseases | Hyperlipidaemia | E78 | HCAR2 |
I00-I99: Diseases of the circulatory system | High blood pressure | I10-I16 | CA2 |
H00-H59: Diseases of the eye and adnexa | Ocular hypertension | H40.0 | CA4; CA4 |
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | CA4; CA2 |
I00-I99: Diseases of the circulatory system | Arteriosclerosis | I70 | HCAR2 |
I00-I99: Diseases of the circulatory system | Atherosclerosis | I70 | HCAR2 |
W85-W99: Exposure to electric current, radiation and extreme ambient air temperature and pressure | Diagnostic test to differentiate primary and secondary hypothyroidism | W88 | TSHR |
H00-H59: Diseases of the eye and adnexa | Glaucoma | H40-H42 | CA1; CA1 |
NA: NA | Colour dead tissues | NA | PTPN1 |
C00-D49: Neoplasms | Thyroid cancer | C73 | TSHR |
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9 |